MDGL Director Files Intent to Sell $4.5M in Stock via 10b5-1 Plan
MADRIGAL PHARMACEUTICALS, INC.
Subscribe to track MDGL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
MDGL Director Files Intent to Sell $4.5M in Stock via 10b5-1 Plan
Company: MADRIGAL PHARMACEUTICALS, INC. (MDGL) Form: 144 | Filed: 2025-11-13 Significance: Low
Insider: Richard S Levy Title: Director | Relationship: Director
Transaction: • Type: Proposed Sale • Shares: 8,500 • Price: ~$528.94 • Value: $4,495,990 • Owned After: Not Disclosed
Key Insight: This proposed sale is executed under a pre-arranged 10b5-1 trading plan, reducing its significance as a market signal. The transaction value represents a negligible fraction of the company's market cap.
Market Context: The sale constitutes less than 0.04% of the company's market capitalization and shares outstanding, indicating a low impact event.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director has filed a notice of a proposed $4.5 million stock sale under a pre-scheduled 10b5-1 trading plan.
- Market Impact: The transaction is of low materiality, representing approximately 0.04% of the company's market capitalization and is unlikely to have a significant market impact.
Company Information
| Field | Value |
|---|---|
| Company | MADRIGAL PHARMACEUTICALS, INC. |
| Ticker Symbol | MDGL |
| CIK | 0001157601 |
| Industry | PHARMACEUTICAL PREPARATIONS |
Insider Information
| Field | Value |
|---|---|
| Name | Richard S Levy |
| CIK | 0001454983 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-13 |
| Transaction Code | Not Applicable |
| Security Type | Common Stock |
| Shares Involved | 8,500 |
| Price Per Share | $528.94 |
| Total Value | $4,495,990 |
| Shares Owned After | Not Disclosed |
| Ownership Type | Not Disclosed |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $4,495,990 |
| % of Market Cap | 0.04% |
| Shares Transacted | 8,500 |
| % of Shares Outstanding | 0.038% |
| Post-Transaction Ownership | Not Disclosed |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with an $11.26 billion market capitalization, this $4.5 million transaction is minor and considered routine portfolio management for an executive.
- Transaction Significance: The sale represents a very small fraction of both the market capitalization (0.04%) and shares outstanding (0.038%), falling well below thresholds for moderate or high significance.
Additional Context
Special Circumstances
- 10b5-1 Plan: The filing explicitly states that the proposed sale is pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025. This indicates the sale was pre-planned and is not based on recent non-public information.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.